Research, Development, And Testing Services - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Research, industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Research, Development, And Testing Services - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Research, Development, And Testing Services
Corporate Insider Buy Sell Ratio (Insider Count) - Research, Development, And Testing Services
Research, Development, And Testing Services - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2026-03-03 ABSI / Absci Corporation 4 McClain Sean F - Taxes D 2.80 -25,316
2026-03-03 ABSI / Absci Corporation 4/A Bedrick Todd F - Taxes D 2.80 -5,282
2026-03-03 ABSI / Absci Corporation 4 Bedrick Todd F - Taxes D 2.80 -5,282
2026-03-03 ABSI / Absci Corporation 4 Jonasson Zachariah F - Taxes D 2.80 -10,848
2026-03-03 ABSI / Absci Corporation 4 Walker Shelby J. F - Taxes D 2.80 -9,825
2026-03-03 ABSI / Absci Corporation 4/A Jonasson Zachariah F - Taxes D 2.80 -10,848
2026-03-03 ABSI / Absci Corporation 4/A McClain Sean F - Taxes D 2.80 -25,316
2026-03-02 ABSI / Absci Corporation 4 Jonasson Zachariah F - Taxes D 2.74 -8,307
2026-03-02 ABSI / Absci Corporation 4 Walker Shelby J. A - Award D 90,300
2026-03-02 CRL / Charles River Laboratories International, Inc. 4 FOSTER JAMES C A - Award D 178.61 16,796
2026-03-02 ABSI / Absci Corporation 4 Pangalos Menelas N A - Award D 5,800
2026-03-02 ABSI / Absci Corporation 4/A Jonasson Zachariah A - Award D 135,400
2026-03-02 ABSI / Absci Corporation 4 McClain Sean A - Award D 406,200
2026-03-02 ABSI / Absci Corporation 4/A Walker Shelby J. A - Award D 90,300
2026-03-02 ABSI / Absci Corporation 4/A McClain Sean A - Award D 406,200
2026-03-02 ABSI / Absci Corporation 4/A Bedrick Todd A - Award D 49,600
2026-03-02 ABSI / Absci Corporation 4 Bedrick Todd A - Award D 49,600
2026-03-02 ABSI / Absci Corporation 4 Jonasson Zachariah A - Award D 135,400
2026-02-27 ABSI / Absci Corporation 4 Pangalos Menelas N P - Purchase D 2.74 75,095
2026-02-23 NEO / NeoGenomics, Inc. 4 Stone Warren M - Exercise D 8,443
2026-02-23 ABSI / Absci Corporation 4 McClain Sean M - Exercise D 1.21 396,399
2026-02-23 NEO / NeoGenomics, Inc. 4 Sherman Jeffrey Scott M - Exercise D 15,535
2026-02-23 NEO / NeoGenomics, Inc. 4 Olivo Alicia C M - Exercise D 8,443
2026-02-23 ABSI / Absci Corporation 4 McClain Sean F - Taxes D 2.65 -267,008
2026-02-23 NEO / NeoGenomics, Inc. 4 Sherman Jeffrey Scott F - Taxes D -3,783
2026-02-23 NEO / NeoGenomics, Inc. 4 Olivo Alicia C F - Taxes D -3,323
2026-02-23 NEO / NeoGenomics, Inc. 4 Stone Warren F - Taxes D -3,323
2026-02-21 NEO / NeoGenomics, Inc. 4 Stone Warren M - Exercise D 28,105
2026-02-21 NEO / NeoGenomics, Inc. 4 Olivo Alicia C M - Exercise D 21,079
2026-02-21 NEO / NeoGenomics, Inc. 4 Aunan Greg D M - Exercise D 6,323
2026-02-21 NEO / NeoGenomics, Inc. 4 Sherman Jeffrey Scott M - Exercise D 42,158
2026-02-21 NEO / NeoGenomics, Inc. 4 Sherman Jeffrey Scott F - Taxes D -10,729
2026-02-21 NEO / NeoGenomics, Inc. 4 Olivo Alicia C F - Taxes D -8,295
2026-02-21 NEO / NeoGenomics, Inc. 4 Stone Warren F - Taxes D -7,142
2026-02-21 NEO / NeoGenomics, Inc. 4 Aunan Greg D F - Taxes D -1,875
2026-02-19 INCY / Incyte Corporation 4 CAGNONI PABLO J S - Sale D 100.91 -18,668
2026-02-19 INCY / Incyte Corporation 4 CAGNONI PABLO J M - Exercise D 61.18 5,575
2026-02-19 INCY / Incyte Corporation 4 CAGNONI PABLO J M - Exercise D 61.76 13,093
2026-02-18 OABI / OmniAb, Inc. 4 Berkman Charles S S - Sale D 1.71 -9,673
2026-02-18 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W S - Sale D 1.71 -30,843
2026-02-18 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A S - Sale D 1.71 -9,301
2026-02-18 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A M - Exercise D 18,750
2026-02-18 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W M - Exercise D 58,333
2026-02-18 OABI / OmniAb, Inc. 4 Berkman Charles S M - Exercise D 18,750
2026-02-17 OABI / OmniAb, Inc. 4 Berkman Charles S S - Sale D 1.70 -6,990
2026-02-17 NOTV / Inotiv, Inc. 4 Sagartz John E S - Sale D 0.2908 -2,119
2026-02-17 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W S - Sale D 1.70 -20,754
2026-02-17 NOTV / Inotiv, Inc. 4 Taylor Beth S - Sale D 0.2929 -2,888
2026-02-17 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A S - Sale D 1.70 -6,828
2026-02-17 NOTV / Inotiv, Inc. 4 Leasure Robert Jr. S - Sale D 0.2953 -16,810
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)